Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.616
+0.025 (4.21%)
At close: Dec 5, 2025, 4:00 PM EST
0.610
-0.006 (-1.01%)
After-hours: Dec 5, 2025, 7:58 PM EST
RVPH Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 71 | 84 | 144 | 87 | 40 | 81 | |
| Market Cap Growth | 68.24% | -41.36% | 65.49% | 115.01% | -49.95% | 195.66% | |
| Enterprise Value | 58 | 79 | 139 | 64 | 7 | 114 | |
| Last Close Price | 0.62 | 1.81 | 5.15 | 4.25 | 2.89 | 8.74 | |
| PB Ratio | 13.05 | 103.76 | 25.14 | 10.35 | 1.41 | 14.77 | |
| P/TBV Ratio | 15.58 | 103.76 | 25.14 | 10.35 | 1.41 | 14.77 | |
| Debt / Equity Ratio | - | 0.56 | - | - | - | - | |
| Quick Ratio | 1.35 | 0.92 | 1.36 | 1.86 | 12.66 | 6.57 | |
| Current Ratio | 1.39 | 1.01 | 1.38 | 1.90 | 13.39 | 6.58 | |
| Return on Equity (ROE) | - | -916.17% | -556.38% | -152.43% | -49.91% | - | |
| Return on Assets (ROA) | -130.48% | -98.20% | -115.85% | -70.11% | -31.45% | -34.72% | |
| Return on Capital (ROIC) | - | -550.81% | -349.89% | -95.16% | -36.98% | -125.79% | |
| Return on Capital Employed (ROCE) | -499.00% | -3416.10% | -605.40% | -315.00% | -34.80% | -32.80% | |
| Earnings Yield | -32.10% | -35.49% | -27.31% | -32.53% | -21.09% | -4.69% | |
| Buyback Yield / Dilution | -72.64% | -39.28% | -21.94% | -31.95% | -383.10% | -10.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.